NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 46 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $393,032 | +19.2% | 259,000 | 0.0% | 0.00% | – |
| Q2 2023 | $329,739 | -5.0% | 259,000 | 0.0% | 0.00% | – |
| Q1 2023 | $347,029 | -14.7% | 259,000 | 0.0% | 0.00% | – |
| Q4 2022 | $406,765 | +27.9% | 259,000 | +15.1% | 0.00% | – |
| Q3 2022 | $318,000 | +139.1% | 225,000 | +125.0% | 0.00% | – |
| Q3 2021 | $133,000 | -71.9% | 100,000 | -71.0% | 0.00% | – |
| Q1 2021 | $473,000 | -92.2% | 345,000 | -92.2% | 0.00% | -100.0% |
| Q4 2020 | $6,066,000 | +159.6% | 4,400,000 | +147.9% | 0.00% | -25.0% |
| Q2 2019 | $2,337,000 | -0.9% | 1,775,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $2,359,000 | +35.1% | 1,775,000 | +18.3% | 0.00% | 0.0% |
| Q4 2018 | $1,746,000 | +435.6% | 1,500,000 | +566.7% | 0.00% | +300.0% |
| Q2 2018 | $326,000 | – | 225,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |